Bachem Holding Future Growth
Future criteria checks 2/6
Bachem Holding is forecast to grow earnings and revenue by 17.9% and 18.2% per annum respectively. EPS is expected to grow by 17.5% per annum. Return on equity is forecast to be 12.7% in 3 years.
Key information
17.9%
Earnings growth rate
17.5%
EPS growth rate
Life Sciences earnings growth | 26.3% |
Revenue growth rate | 18.2% |
Future return on equity | 12.7% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,004 | 192 | -100 | 177 | 7 |
12/31/2025 | 782 | 145 | -76 | 216 | 7 |
12/31/2024 | 621 | 119 | -42 | 222 | 7 |
6/30/2024 | 578 | 114 | -53 | 244 | N/A |
3/31/2024 | 578 | 113 | -36 | 247 | N/A |
12/31/2023 | 577 | 112 | -19 | 250 | N/A |
9/30/2023 | 557 | 105 | -40 | 193 | N/A |
6/30/2023 | 537 | 99 | -62 | 137 | N/A |
3/31/2023 | 534 | 100 | -56 | 115 | N/A |
12/31/2022 | 532 | 101 | -50 | 93 | N/A |
9/30/2022 | 515 | 99 | -47 | 91 | N/A |
6/30/2022 | 499 | 98 | -44 | 88 | N/A |
3/31/2022 | 501 | 106 | -32 | 93 | N/A |
12/31/2021 | 503 | 115 | -19 | 98 | N/A |
9/30/2021 | 484 | 107 | 1 | 107 | N/A |
6/30/2021 | 464 | 98 | 21 | 116 | N/A |
3/31/2021 | 433 | 88 | 34 | 116 | N/A |
12/31/2020 | 402 | 78 | 46 | 115 | N/A |
9/30/2020 | 379 | 72 | 47 | 103 | N/A |
6/30/2020 | 356 | 67 | 47 | 91 | N/A |
3/31/2020 | 335 | 60 | 41 | 78 | N/A |
12/31/2019 | 314 | 54 | 34 | 64 | N/A |
9/30/2019 | 310 | 52 | 28 | 60 | N/A |
6/30/2019 | 306 | 51 | 22 | 57 | N/A |
3/31/2019 | 294 | 49 | 5 | 41 | N/A |
12/31/2018 | 283 | 47 | -12 | 26 | N/A |
9/30/2018 | 268 | 45 | -17 | 24 | N/A |
6/30/2018 | 253 | 42 | -21 | 23 | N/A |
3/31/2018 | 257 | 42 | N/A | 30 | N/A |
12/31/2017 | 262 | 42 | N/A | 36 | N/A |
9/30/2017 | 252 | 41 | N/A | 36 | N/A |
6/30/2017 | 242 | 40 | N/A | 35 | N/A |
3/31/2017 | 239 | 41 | N/A | 38 | N/A |
12/31/2016 | 236 | 41 | N/A | 40 | N/A |
9/30/2016 | 229 | 39 | N/A | 46 | N/A |
6/30/2016 | 222 | 36 | N/A | 52 | N/A |
3/31/2016 | 216 | 34 | N/A | 57 | N/A |
12/31/2015 | 209 | 32 | N/A | 61 | N/A |
9/30/2015 | 203 | 31 | N/A | 59 | N/A |
6/30/2015 | 197 | 29 | N/A | 57 | N/A |
3/31/2015 | 190 | 29 | N/A | 52 | N/A |
12/31/2014 | 184 | 29 | N/A | 47 | N/A |
9/30/2014 | 180 | 27 | N/A | 45 | N/A |
6/30/2014 | 176 | 26 | N/A | 44 | N/A |
3/31/2014 | 173 | 25 | N/A | 46 | N/A |
12/31/2013 | 171 | 24 | N/A | 49 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BHM's forecast earnings growth (17.9% per year) is above the savings rate (1%).
Earnings vs Market: BHM's earnings (17.9% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: BHM's earnings are forecast to grow, but not significantly.
Revenue vs Market: BHM's revenue (18.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: BHM's revenue (18.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BHM's Return on Equity is forecast to be low in 3 years time (12.7%).